SITAGLIPTIN VERSUS PLACEBO IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL

被引：5

作者：

Cui, J. Y. ^{[1
]}

Philo, L. ^{[2
]}

Nguyen, P. ^{[1
]}

Hofflich, H. ^{[3
]}

Hernandez, C. ^{[1
]}

Bettencourt, R. ^{[4
]}

Richards, L. ^{[1
]}

Salotti, J. ^{[1
]}

Bhatt, A. ^{[1
]}

Hooker, J. ^{[5
]}

Haufe, W. ^{[5
]}

Hooker, C. ^{[1
]}

Brenner, D. A. ^{[6
]}

Sirlin, C. B. ^{[5
]}

Loomba, R. ^{[1
,4
,6
,7
]}

机构：

[1] UC San Diego Sch Med, Dept Med, NAFLD Res Ctr, La Jolla, CA USA

[2] Naval Med Ctr, San Diego, CA USA

[3] UC San Diego Sch Med, Div Gen Internal Med, La Jolla, CA USA

[4] UC San Diego Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA USA

[5] UC San Diego Sch Med, Dept Radiol, Liver Imaging Grp, La Jolla, CA USA

[6] UC San Diego Sch Med, Dept Med, Div Gastroenterol, La Jolla, CA USA

[7] San Diego Integrated NAFLD Consortium, San Diego, CA USA

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)00137-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS112

引用

页码：S192 / S193

页数：2

共 50 条

[31] Treatment of Non-Alcoholic Fatty Liver Disease [J].

Dyson, Jessica ;

Day, Chris .

DIGESTIVE DISEASES, 2014, 32 (05) :597-604

[32] A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease [J].

Fernandez-Miranda, C. ;

Perez-Carreras, M. ;

Colina, F. ;

Lopez-Alonso, G. ;

Vargas, C. ;

Solis-Herruzo, J. A. .

DIGESTIVE AND LIVER DISEASE, 2008, 40 (03) :200-205

[33] Treatment of non-alcoholic fatty liver disease [J].

Adams, LA ;

Angulo, P .

POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (967) :315-322

[34] The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial [J].

Tehrani, Asal Neshatbini ;

Hatami, Behzad ;

Daftari, Ghazal ;

Hekmatdoost, Azita ;

Yari, Zahra ;

Salehpour, Amin ;

Hosseini, Seyed Ahmad ;

Helli, Bizhan .

BMC PUBLIC HEALTH, 2024, 24 (01)

[35] The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial [J].

Mohamed, Amal Ahmed ;

Halim, Ahmed Abdel ;

Mohamed, Sahar ;

Mahmoud, Seham Mohamed ;

Eldemiry, Eman Mohamed Bahgat ;

Mohamed, Rasha Sobh ;

Shaheen, Mahmoud Maamoun ;

Naguib, Gina G. ;

Muharram, Nashwa M. ;

Khalil, Mona G. ;

Saed, Salma ;

Ibrahim, Randa ;

Seif, Ahmed Salah ;

Kamal, Noha ;

Nasraldin, Karima ;

Abdelrahman, Ali Elsaid ;

El Borolossy, Radwa .

FRONTIERS IN PHARMACOLOGY, 2023, 14

[36] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease [J].

Weiner, R. A. .

DIGESTIVE DISEASES, 2010, 28 (01) :274-279

[37] Empagliflozin for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials [J].

Tang, Xue ;

Zhang, Huaping ;

Wang, Xin ;

Yang, Dan .

AFRICAN HEALTH SCIENCES, 2022, 22 (03) :391-398

[38] Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial [J].

Wong, Vincent Wai-Sun ;

Chan, Ruth Suk-Mei ;

Wong, Grace Lai-Hung ;

Cheung, Bernice Ho-Ki ;

Chu, Winnie Chiu-Wing ;

Yeung, David Ka-Wai ;

Chim, Angel Mei-Ling ;

Lai, Jennifer Wing-Yan ;

Li, Liz Sin ;

Sea, Mandy Man-Mei ;

Chan, Francis Ka-Leung ;

Sung, Joseph Jao-Yiu ;

Woo, Jean ;

Chan, Henry Lik-Yuen .

JOURNAL OF HEPATOLOGY, 2013, 59 (03) :536-542

[39] Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial [J].

贾国瑜 .

ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (02) :107-108

[40] Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial [J].

Varkaneh, Hamed Kord ;

Sahlabadi, Ammar Salehi ;

Gaman, Mihnea-Alexandru ;

Rajabnia, Mohsen ;

Macit-Celebi, Melahat Sedanur ;

Santos, Heitor O. ;

Hekmatdoost, Azita .

FRONTIERS IN NUTRITION, 2022, 9

← 1 2 3 4 5 →